Torthaí cuardaigh - Atul Mehta
- 1 - 20 toradh as 57 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Glucose-6-phosphate dehydrogenase deficiency de réir Atul Mehta
Foilsithe / Cruthaithe 1994Revisão -
2
Gaucher disease: haematological presentations and complications de réir Alison Thomas, Atul Mehta, Derralynn Hughes
Foilsithe / Cruthaithe 2014Revisão -
3
How we manage Gaucher Disease in the era of choices de réir Shoshana Revel‐Vilk, Jeff Szer, Atul Mehta, Ari Zimran
Foilsithe / Cruthaithe 2018Revisão -
4
-
5
-
6
Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation de réir John Goulis, T N Chau, S Jordan, Atul Mehta, A. Watkinson, Keith Rolles, Andrew K. Burroughs
Foilsithe / Cruthaithe 1999Artigo -
7
Evolution of Prodromal Clinical Markers of Parkinson Disease in a<i>GBA</i>Mutation–Positive Cohort de réir Michelle Beavan, Alisdair McNeill, Christos Proukakis, Derralynn Hughes, Atul Mehta, Anthony H.V. Schapira
Foilsithe / Cruthaithe 2014Artigo -
8
Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey de réir Aleš Linhart, Christoph Kampmann, José Luis Zamorano, Gere Sunder‐Plassmann, Michael Beck, Atul Mehta, Perry Elliott
Foilsithe / Cruthaithe 2007Artigo -
9
Clinical prodromes of neurodegeneration in Anderson-Fabry disease de réir Matthias Löhle, Derralynn Hughes, Alan Milligan, Linda Richfield, Heinz Reichmann, Atul Mehta, Anthony H.V. Schapira
Foilsithe / Cruthaithe 2015Artigo -
10
The Binary Endocardial Appearance Is a Poor Discriminator of Anderson-Fabry Disease From Familial Hypertrophic Cardiomyopathy de réir Stavros P. Kounas, Camelia Demetrescu, Antonios Pantazis, Andre Keren, Philip Lee, Derralynn Hughes, Atul Mehta, Perry Elliott
Foilsithe / Cruthaithe 2008Artigo -
11
Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey de réir Atul Mehta, Joe T.R. Clarke, Roberto Giugliani, Perry Elliott, Aleš Linhart, Michael Beck, Gere Sunder‐Plassmann
Foilsithe / Cruthaithe 2009Artigo -
12
Stages of T-cell receptor protein expression in T-cell acute lymphoblastic leukemia de réir Dario Campana, JJ van Dongen, Atul Mehta, Elaine Coustan‐Smith, IL Wolvers-Tettero, K. Ganeshaguru, George Janossy
Foilsithe / Cruthaithe 1991Artigo -
13
Phenotype and biochemical heterogeneity in late onset Fabry disease defined by N215S mutation de réir Lucia Lavalle, A. Thomas, Brendan Beaton, H. Ebrahim, Malcolm Reed, Uma Ramaswami, Perry Elliott, Atul Mehta, Derralynn Hughes
Foilsithe / Cruthaithe 2018Artigo -
14
A charitable access program for patients with lysosomal storage disorders in underserved communities worldwide de réir Atul Mehta, Uma Ramaswami, Joseph Muenzer, Roberto Giugliani, Kurt Ullrich, Tanya Collin-Histed, Zoya Panahloo, Hartmann Wellhoefer, Joel Frader
Foilsithe / Cruthaithe 2021Artigo -
15
Fabry disease: a review of current management strategies de réir Atul Mehta, Michael Beck, F. Eyskens, Claudio Feliciani, Ilkka Kantola, Uma Ramaswami, A. Rolfs, A. Rivera, S. Waldek, Dominique P. Germain
Foilsithe / Cruthaithe 2010Revisão -
16
Gaucher Cells Demonstrate a Distinct Macrophage Phenotype and Resemble Alternatively Activated Macrophages de réir Leonie A. Boven, Marjan van Meurs, Rolf G. Boot, Atul Mehta, Louis Boon, Johannes M. F. G. Aerts, Jon D. Laman
Foilsithe / Cruthaithe 2004Artigo -
17
Cardiac Fabry Disease With Late Gadolinium Enhancement Is a Chronic Inflammatory Cardiomyopathy de réir Sabrina Nordin, Rebecca Kozor, Heerajnarain Bulluck, Silvia Castelletti, Stefania Rosmini, Amna Abdel‐Gadir, Shanat Baig, Atul Mehta, Derralynn Hughes, James Moon
Foilsithe / Cruthaithe 2016Carta -
18
Assessment of plasma lyso-Gb3 for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease de réir Daniel G. Bichet, Johannes M. F. G. Aerts, Christiane Auray‐Blais, Hiroki Maruyama, Atul Mehta, Nina Skuban, Eva Krusinska, Raphael Schiffmann
Foilsithe / Cruthaithe 2020Artigo -
19
Gaucher Cells Demonstrate a Distinct Macrophage Phenotype and Resemble Alternatively Activated Macrophages de réir Leonie A. Boven, Marjan van Meurs, Rolf G. Boot, Atul Mehta, Louis Boon, Johannes M. F. G. Aerts, Jon D. Laman
Foilsithe / Cruthaithe 2004Artigo -
20
Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis de réir Michael Beck, Derralynn Hughes, Christoph Kampmann, Sylvain Larroque, Atul Mehta, Guillem Pintos‐Morell, Uma Ramaswami, Michael L. West, Anna Wijatyk, Roberto Giugliani
Foilsithe / Cruthaithe 2015Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Internal medicine
Disease
Fabry disease
Enzyme replacement therapy
Biology
Pediatrics
Gene
Glucocerebrosidase
Genetics
Surgery
Biochemistry
Cardiology
Intensive care medicine
Parkinson's disease
Cohort
Endocrinology
Mutation
Pathology
Adverse effect
Blood pressure
Chemistry
Gastroenterology
Globotriaosylceramide
Heart failure
Immunology
Renal function
Cardiomyopathy
Clinical endpoint
Clinical trial